The Biggest CAR-TCR Meeting Just Got BIGGER

The hotly anticipated 7th Annual CAR-TCR Summit is back, bigger and better than ever, uniting experts with one common goal: engineering a disease-free world.

After the explosive news that CAR-T therapies can now be considered curative, now is the time to unite with your industry, from the long-standing commercial giants to the trailblazing pioneers, and discover new strategies for everything from discovery to early phase development to commercialization.

Gain end-to-end insights from both established thought leaders and the innovators bringing disruptive technologies from bench to bedside and from vein to vein.

Across 3 conference days with 8 tracks, 15 Workshops, 1 Bootcamp and 1 Focus Day, 200+ CAR and TCR experts will lead you and 1,000 of your peers in discussions that will accelerate your pipeline and bring much-needed treatments to patients faster.

You can’t afford to miss the 7th CAR-TCR Summit as we bring you more speakers, more content and more exclusive insights than ever before!

View the Full Event Guide Now!

Download your copy to see all the 2022 speakers, full agenda breakdown, partners and how you can access the best possible rates.

200+ Expert Speakers Including:

Bruce Levine

Barbara & Edward Netter Professor in Cancer Gene Therapy

University of Pennsylvania

Christina Coughlin

Chief Executive Officer

Cytoimmune

Nicholas Boyle

Co-Founder, Chief Executive Officer

Abintus Bio

Bob Valamehr

Chief Research & Development Officer

Fate Therapeutics

Brent Rice

Senior Vice President, Chief Commercial Officer

Autolus

Ellie Corigliano

Head of CDx Cell & Gene Therapy, Global Clinical Development

GSK

Lynelle Hoch

Senior Vice President

Bristol Myers Squibb

Debora Barton

Chief Medical Officer

Carisma Therapeutics

Gary Lee

Chief Scientific Officer

Lyell Pharma

Karen Walker

Chief Technology Officer

Kyverna Therapeutics

Qi Cai

Director of Biology

Kite Pharma

SEE ALL SPEAKERS

What’s New for 2022?

New Companies

Join new companies that have NEVER spoken before such as Currus Biologics, ImmTune Therapies, Rootpath, Strand Therapeutics, Deverra Therapeutics and more as they share new cutting-edge platforms and technologies.

3 Main Conference Days

As the cell therapy space continues to explode with new companies popping up and clinical collaborations driving the field forward, we are keeping up with this growth by bringing you even more content including a new third conference day!

CMC/Analytics Track

A very popular new addition to the program – the brand new track dedicated to CMC and analytical innovations that are paving the way for greater understanding and characterization of cell products to best showcase quality, safety and potency.

Investors Roundtable

Gathering expert venture capitalists, business angels and corporate venture funds, gain insights into the current priorities of investors, what excites them and how to set your company apart to raise financing and secure reliable streams of capital.

FULL EVENT GUIDE